Therapeutics and Targets: Experimental Therapeutics– Small Molecules

Contributing journals to this collection:
Cancer Prevention Journals Portal, Cancer Prevention Journals Portal Content, , Cancer Reviews Online, Molecular Cancer Research, Cancer Prevention Research, Molecular Cancer Therapeutics, Cancer Research, Cancer Reviews Online Content, Clinical Cancer Research, and Cancer Epidemiology Biomarkers & Prevention

Citations 1-10 of 30 total displayed.

Most recent content

Review
Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling

Scott M. Wilhelm, Lila Adnane, Philippa Newell, Augusto Villanueva, Josep M. Llovet, and Mark Lynch
Mol. Cancer Ther. 2008; 7: 3129-3140. [Abstract] [Full text] [PDF]  

Past content

Review
Mammalian target of rapamycin inhibition as a therapeutic strategy in the management of urologic malignancies

Jorge A. Garcia and David Danielpour
Mol. Cancer Ther. 2008; 7: 1347-1354. [Abstract] [Full text] [PDF]  

Review
Competitive or noncompetitive, that's the question: research toward histone deacetylase inhibitors

Hong Su, Lucia Altucci, and Qidong You
Mol. Cancer Ther. 2008; 7: 1007-1012. [Abstract] [Full text] [PDF]  

Focus Section
Newer Cytotoxic Agents: Attacking Cancer Broadly

Beverly A. Teicher
Clin. Cancer Res. 2008; 14: 1610-1617. [Abstract] [Full text] [PDF]  

Focus Section
The Epothilones: Translating from the Laboratory to the Clinic

James J. Lee and Sandra M. Swain
Clin. Cancer Res. 2008; 14: 1618-1624. [Abstract] [Full text] [PDF]  

Focus Section
Vinflunine: A New Microtubule Inhibitor Agent

Jaafar Bennouna, Jean-Pierre Delord, Mario Campone, and Laurent Nguyen
Clin. Cancer Res. 2008; 14: 1625-1632. [Abstract] [Full text] [PDF]  

Focus Section
Current Status and Future Prospects for Satraplatin, an Oral Platinum Analogue

Hak Choy, Clinton Park, and Min Yao
Clin. Cancer Res. 2008; 14: 1633-1638. [Abstract] [Full text] [PDF]  

Focus Section
Aurora Kinases as Anticancer Drug Targets

Oliver Gautschi, Jim Heighway, Philip C. Mack, Phillip R. Purnell, Primo N. Lara, Jr., and David R. Gandara
Clin. Cancer Res. 2008; 14: 1639-1648. [Abstract] [Full text] [PDF]  

Focus Section
Proteasome Inhibitors in Cancer Therapy: Lessons from the First Decade

Robert Z. Orlowski and Deborah J. Kuhn
Clin. Cancer Res. 2008; 14: 1649-1657. [Abstract] [Full text] [PDF]  

Reviews
Cannabinoids for Cancer Treatment: Progress and Promise

Sami Sarfaraz, Vaqar M. Adhami, Deeba N. Syed, Farrukh Afaq, and Hasan Mukhtar
Cancer Res. 2008; 68: 339-342. [Abstract] [Full text] [PDF]  

[Next page] Pages: 1 2 3